New combo therapy fights rare, tough cancers
NCT ID NCT02406781
Summary
This study tested whether combining an immunotherapy drug (MK3475) with a low-dose chemotherapy (cyclophosphamide) could help control advanced sarcomas, a group of rare cancers. It involved 129 adults whose cancer had progressed despite prior treatments. The main goal was to see if the combination could shrink tumors or stop them from growing for at least six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Léon Bérard
Lyon, 69373, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut Claudius Regaud
Toulouse, 31052, France
-
Institut Curie
Paris, 75005, France
-
Institut Gustave Roussy
Villejuif, 94800, France
-
Institut Paoli Calmettes
Marseille, 13273, France
-
Institut de Cancérologie de l'Ouest
Saint-Herblain, 44805, France
Conditions
Explore the condition pages connected to this study.